
FY1 Teaching May 2025 | Robert Hunter
assessing kidney disease
common pathologies
investigations
management of AKI
prescribing
when & how to refer
assessing kidney disease
common pathologies
investigations
management of AKI
prescribing
when & how to refer

Often person on the team who will know the most
AKI in 10 - 20% of hospital admissions.
CKD in 10% (and therefore presumably much higher in hospital population).
750 nephrologists in UK and 250,000 doctors = 0.3%.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
What is her GFR?
What is the best measure of current kidney function?
What would you like to know in Hx and Ex?
What fluids would you prescribe?
How would you manage her AKI?
Now what fluids would you prescribe?
Why have the IV fluids not provoked a urine output?
Why does she have an AKI?
Does she have CKD?
What investigations would you request?
Would you refer to renal?
Meta-analysis (NEJM Evidence 2022); n = 35,000 balanced vs. saline in critical care. Likely mortality benefit but v. v. small effect size (90% likely in Bayesian analysis). Evidence of harm in traumatic brain injury.
Err towards balanced crystalloids. Be aggressive in first 6 hrs (golden hours); conservative after this. Fluids are ‘thrombolysis’ for the kidney.
Special circumstances:
vomiting / alkalosis
brain injury
cirrhosis
hyponatraemia
hyperkalaemia
aspirin 75 mg od
amlodipine 10 mg od
atenolol 25 mg od
simvastatin 40 mg od
paracetamol 1g qds
morphine sulphate 10 mg prn 1 hrly
dalteparin 5000 units s.c.
piperacillin/tazobactam 4.5g IV tds
What would you do with her drugs now? What would you do with her drugs next week?
when:
know:
urine output = GFR now
always plot Cr (or eGFR)
blood and protein on dip = intrinsic renal disease
uACR or uPCR to quantify proteinuria (see the dog on fire)
concept of impaired autoregulation of RBF
correct hypovolaemia then stop





Images on left show capillaries in buccal mucosa in a patient with sepsis (Vincent & De Backer, NEJM 2013).
Images on right show stripping of capillary glycocalyx in rat model of sepsis.


Think twice about drugs & sepsis (STOP)
Thadhani et al (NEJM, 1996); Abeulo et al (NEJM 2007); Vincent & De Backer (NEJM, 2013)




Red = directly nephrotoxic
Purple = accumulate in renal failure
Blue = harmful when stopped and not re-started
Should we stop ACEi?
Should we have sick day rules?
Cr plot gallery
volume assessment
renal haemodynamics
proteinuria

Myeloma + contrast

DKD

AIN (Sjogrens)

ATI (sepsis / ortho)

RAS + ACEi
postural changes
always helpful…
- urine output (+/- catheter)- fluid balance chart- weight chartPotential confounders in peripheral perfusion / postural changes… Oedema – where / semi-quantitative / absence of oedema Lie flat for JVP Relative hypotension: Liu et al (NDT 2009)
sepsis
heart failure
nephrotic syndrome
young people

Vincent & De Backer (NEJM, 2013)
individual signs unreliable (unless at extremes – e.g. JVP < 1 or > 10 cm)
quantify oedema (can even be negative!)
almost never “intravascularly deplete but extravascular overload”
Bayesian approach
EABV = “a poorly measurable quality of arterial filling determined primarily by blood volume, cardiac output, and vascular tone”
Blood distributed 85 % in venous; 15 % arterial. The description “ECF overload but intravascularly deplete” is usually wrong. Rather there is reduced EABV. Studies in CCF and cirrhosis – showing overall vascular expansion but re-distribution into venous (e.g. splanchnic) circulations.







- usually ignore trace results - dip ‘+’ = 30 mg/dL = PER 0.5 g/d = overt proteinuria - dip ‘+++’ = 300 mg/dL = PER 1–2 = heavy proteinuria - to convert PCR to PER, divide by 100 - ACR >220, PCR >350, PER > 3.5 g/d = nephrotic 
assessing kidney disease
common pathologies
investigations
management of AKI
prescribing
when & how to refer
Keyboard shortcuts
| ↑, ←, Pg Up, k | Go to previous slide |
| ↓, →, Pg Dn, Space, j | Go to next slide |
| Home | Go to first slide |
| End | Go to last slide |
| Number + Return | Go to specific slide |
| b / m / f | Toggle blackout / mirrored / fullscreen mode |
| c | Clone slideshow |
| p | Toggle presenter mode |
| t | Restart the presentation timer |
| ?, h | Toggle this help |
| o | Tile View: Overview of Slides |
| Esc | Back to slideshow |

FY1 Teaching May 2025 | Robert Hunter
assessing kidney disease
common pathologies
investigations
management of AKI
prescribing
when & how to refer
assessing kidney disease
common pathologies
investigations
management of AKI
prescribing
when & how to refer

Often person on the team who will know the most
AKI in 10 - 20% of hospital admissions.
CKD in 10% (and therefore presumably much higher in hospital population).
750 nephrologists in UK and 250,000 doctors = 0.3%.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
Smoker, EtOH XS, hip replacement, HTN on two agents.
Getting worse after 7 days in hospital. Not for ITU.
What is her GFR?
What is the best measure of current kidney function?
What would you like to know in Hx and Ex?
What fluids would you prescribe?
How would you manage her AKI?
Now what fluids would you prescribe?
Why have the IV fluids not provoked a urine output?
Why does she have an AKI?
Does she have CKD?
What investigations would you request?
Would you refer to renal?
Meta-analysis (NEJM Evidence 2022); n = 35,000 balanced vs. saline in critical care. Likely mortality benefit but v. v. small effect size (90% likely in Bayesian analysis). Evidence of harm in traumatic brain injury.
Err towards balanced crystalloids. Be aggressive in first 6 hrs (golden hours); conservative after this. Fluids are ‘thrombolysis’ for the kidney.
Special circumstances:
vomiting / alkalosis
brain injury
cirrhosis
hyponatraemia
hyperkalaemia
aspirin 75 mg od
amlodipine 10 mg od
atenolol 25 mg od
simvastatin 40 mg od
paracetamol 1g qds
morphine sulphate 10 mg prn 1 hrly
dalteparin 5000 units s.c.
piperacillin/tazobactam 4.5g IV tds
What would you do with her drugs now? What would you do with her drugs next week?
when:
know:
urine output = GFR now
always plot Cr (or eGFR)
blood and protein on dip = intrinsic renal disease
uACR or uPCR to quantify proteinuria (see the dog on fire)
concept of impaired autoregulation of RBF
correct hypovolaemia then stop





Images on left show capillaries in buccal mucosa in a patient with sepsis (Vincent & De Backer, NEJM 2013).
Images on right show stripping of capillary glycocalyx in rat model of sepsis.


Think twice about drugs & sepsis (STOP)
Thadhani et al (NEJM, 1996); Abeulo et al (NEJM 2007); Vincent & De Backer (NEJM, 2013)




Red = directly nephrotoxic
Purple = accumulate in renal failure
Blue = harmful when stopped and not re-started
Should we stop ACEi?
Should we have sick day rules?
Cr plot gallery
volume assessment
renal haemodynamics
proteinuria

Myeloma + contrast

DKD

AIN (Sjogrens)

ATI (sepsis / ortho)

RAS + ACEi
postural changes
always helpful…
- urine output (+/- catheter)- fluid balance chart- weight chartPotential confounders in peripheral perfusion / postural changes… Oedema – where / semi-quantitative / absence of oedema Lie flat for JVP Relative hypotension: Liu et al (NDT 2009)
sepsis
heart failure
nephrotic syndrome
young people

Vincent & De Backer (NEJM, 2013)
individual signs unreliable (unless at extremes – e.g. JVP < 1 or > 10 cm)
quantify oedema (can even be negative!)
almost never “intravascularly deplete but extravascular overload”
Bayesian approach
EABV = “a poorly measurable quality of arterial filling determined primarily by blood volume, cardiac output, and vascular tone”
Blood distributed 85 % in venous; 15 % arterial. The description “ECF overload but intravascularly deplete” is usually wrong. Rather there is reduced EABV. Studies in CCF and cirrhosis – showing overall vascular expansion but re-distribution into venous (e.g. splanchnic) circulations.







- usually ignore trace results - dip ‘+’ = 30 mg/dL = PER 0.5 g/d = overt proteinuria - dip ‘+++’ = 300 mg/dL = PER 1–2 = heavy proteinuria - to convert PCR to PER, divide by 100 - ACR >220, PCR >350, PER > 3.5 g/d = nephrotic 